NEOMED receives $12 Million from Federal Government. NEOMED, a not for profit organization whose mission is to create a bridge between academic research and the pharmaceutical industry, will receive $12 million in funding from the Government of Canada to help academic researchers turn their discoveries in to future medicines. NEOMED is the only Quebec recipient in the 2015 Centres of Excellence in Commercialization and Research (CECR) program competition.

Genome Canada and Génome Québec are pleased to announce UCB Canada Inc.’s contribution to a four-year study aimed at developing a personalized medicine approach to the early diagnosis of various types of epilepsy. The $10.8 million project, “Personalized medicine in the treatment of epilepsy”, forms the Canadian Epilepsy Network (CENet) and is led by Dr. Patrick Cossette at the University of Montreal Hospital Research Centre* (CRCHUM), as well as co-leaders, Dr. Jacques Michaud, Sainte-Justine University Hospital Research Center in Montreal, and Dr. Berge Minassian, The Hospital for Sick Children in Toronto. >

A new screening test for lung cancer could prevent thousands of Quebecers invasive biopsy. The blood test was developed by an American company and Caprion, a SME in Montreal. Martin LeBlanc, CEO of Caprion, is the personality of the week of La Presse. Martin LeBlanc is a member of the Board of Directors of the QNPHC. Developed in collaboration with Integrated Diagnostics, a Seattle company, this new blood test permits to evaluate if a lung nodule is benign or malignant. (in French only) >

Quebec strengthens its leadership in personalized health care

The Quebec Network for Personalized Health Care (QNPHC) welcomes with enthusiasm two major initiatives in the development and implementation of personalized health care in Quebec, thereby strengthening Quebec global leadership in the sector. First, the Ste-Justine University Hospital Center (CHU) and Genome Quebec today announced the creation of the first integrated pediatric clinical genomic center in Canada, which will allow children and their parents to benefit from genomic discoveries for improved diagnosis, prevention and treatment of genetic diseases. This initiative is at the forefront of what is being done in the world currently. Second, the new National Research and Innovation Policy (PNRI), which was made public last week with investments of $3.7 billion over five years, will target personalized health care (PHC) as one of Quebec’s priority strategic sectors.Read More